Nickolai V Sinakevich

Title: Innovator Nickolai V Sinakevich: Pioneering Immunomodulating Peptides in St. Petersburg

Introduction

Nickolai V Sinakevich is a notable inventor based in St. Petersburg, Russia. With a keen focus on immunology, he has made significant contributions to the field through his innovative work. His commitment to advancing scientific knowledge and applications is evident in his patented invention that aims to enhance immunomodulation.

Latest Patents

Nickolai holds a patent for "Immunomodulating peptides and methods of use." This invention presents a unique formula of peptides, specifically R'-Glx-Glx-Lys-R', where Glx represents either Glu (Glutamic Acid) or Gln (Glutamine). Notably, the invention includes the peptides Thr-Ala-Glu-Glu-Lys and Thr-Pro-Glu-Glu-Lys. The pharmaceutical compositions developed from these peptides offer potential applications for immunomodulation, thereby contributing to advancements in therapeutic treatments.

Career Highlights

Nickolai is associated with Cytran, Inc., a company that focuses on developing innovative solutions in biotechnology. His work at Cytran showcases his dedication to translating scientific research into real-world applications, particularly in enhancing immune response capabilities through novel peptide formulations.

Collaborations

Throughout his career, Nickolai has collaborated with esteemed colleagues, including Lawrence R Green and Vadim T Ivanov. These partnerships have fostered an environment of shared knowledge and innovation, ultimately leading to the successful development of impactful inventions.

Conclusion

In summary, Nickolai V Sinakevich stands out as a prominent inventor in the field of immunology from St. Petersburg, Russia. His patented immunomodulating peptides exemplify his commitment to advancing medical science and improving human health. Through his work with Cytran, Inc. and collaboration with fellow researchers, he continues to push the boundaries of innovation in biotechnology.